not logged in

European Urology

European Urology

Volume 58, issue 2, pages e19-e28, August 2010

Case Study of the Month

Neoadjuvant Temsirolimus Effectiveness in Downstaging Advanced Non–Clear Cell Renal Cell Carcinoma eulogo1

Oscar Rodríguez Faba, Alberto Breda, Antonio Rosales, Joan Palou, Ferran Algaba, Pablo Maroto Rey and Humberto Villavicencio

Accepted 3 March 2010, Published online 12 March 2010, pages 307 - 310


Conflicts of interest

Joan Palou is a consultant for Sanofi-Pasteur, Lilly, and AMGEN. She receives company speaker honorariums from Sanofi-Pasteur and has participated in trials by Lilly and Zambon Group.


Recommend this article

Currently this article has a rating of 0. Please log in to recommend it.

Articles in this new format: